Conference abstract · 16 Mar 2021
Conference abstractPublished 30 Aug 2017
Using Nanocarriers against Synucleinopathies
National Institute of Genetic Engineering and Biotechnology, Iran.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
α-Synuclein (α-Syn) is a protein presence in the brains of a range of neurodegenerative disorders’ patients as plaque-like compact structures in the form of amyloid fibrils. There is a strong relationship between α-Syn amyloid fibrillation and the pathology of the neurodegenerative disorders such as Parkinson’s disease. There is a serious effort to apply the compounds, known as small molecules, with inhibitory effects on the different steps of α-SN fibrillation and also its related neurotoxicity. However, the small molecules can possess some problems like high hydrophobicity/ low solubility in physiological fluids, instability, and difficulty in passing across blood brain barrier (BBB). In this respect, employing of nanocarriers has been pointed because of a lot of advantages i.e. biocompatibility, easy surface modification, low immunogenicity, protecting cargo against enzymatic degradation. In this regard we used three different nanocarriers including serum albumin nanoparticles (SA- NPs)([1], mesoporous silica nanoparticles (MS-NPs) [2] and neutral charged nanoliposomes(NC-NLPs). We found that each kind of nanocarrier possess specific characters when applying for loading drugs or treating α-Syn or neuronal cells. SA- NPs with a moderate drug loading efficiency (DLE) for polyphenols, showed some inducing effect on α-Syn fibrillation when treating with bare SA- NPs. Although MS-NPs with similar DLE did not show inducing effect on α-Syn fibrillation, they had a small neurotoxicity effect. On the other hand, NC-NLPs had high DLE for polyphenols and also they did not indicate any considerable induction on the α-Syn fibrillation or any neurotoxicity effects. It seems that NC-NLPs have more potential for using regarding synucleinopathies treating than the two other NPs.
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 29 Dec 2025
pH-Sensitive Drug Delivery: Targeted Therapy Through Smart Nanocarriers
Commentary · 30 Jun 2025
Surface-Functionalized Nanocarriers: Advancing Targeted Drug Delivery
Short communication · 29 May 2025
Nanocarriers: Revolutionizing Targeted Drug Delivery and Therapies
Short communication · 29 Mar 2025
Combination Therapy Nanocarriers: Enhancing Therapeutic Efficacy
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- BylineArticles whose byline prints “Dina Morshedi”
